Protein synthesis inhibitor
Appearance
![](http://upload.wikimedia.org/wikipedia/commons/thumb/b/b1/Ribosome_mRNA_translation_en.svg/220px-Ribosome_mRNA_translation_en.svg.png)
A protein synthesis inhibitor is a compound that stops or slows the growth or proliferation of cells by disrupting the processes that lead directly to the generation of new
proteins.[1]
nanoscales to translate
RNA into proteinsWhile a broad interpretation of this definition could be used to describe nearly any compound depending on concentration, in practice, it usually refers to compounds that act at the molecular level on translational machinery (either the ribosome itself or the translation factor),eukaryotic ribosome structures.[citation needed]
Mechanism
In general, protein synthesis inhibitors work at different stages of
peptidyl transfer, and bacterial translocation
) and termination:
Earlier stages
- Rifamycin inhibits bacterial DNA transcription into mRNA by inhibiting DNA-dependent RNA polymerase by binding its beta-subunit.[citation needed]
- alpha-Amanitin is a powerful inhibitor of eukaryotic DNA transcription machinery.[citation needed]
Initiation
- initiation complex, although the mechanism is not fully understood.[4]
Ribosome assembly
- 30S ribosomal subunit.[5]
Aminoacyl tRNA entry
- aminoacyl tRNAs.
Proofreading
- Aminoglycosides, among other potential mechanisms of action, interfere with the proofreading process, causing increased rate of error in synthesis with premature termination.[7]
Peptidyl transfer
- mitochondria.
- Macrolides (as well as inhibiting ribosomal translocation[8]and other potential mechanisms) bind to the 50s ribosomal subunits, inhibiting peptidyl transfer.
- Geneticin, also called G418, inhibits the elongation step in both prokaryotic and eukaryotic ribosomes.[10]
- Trichothecene mycotoxins are potent and non selective inhibitors of peptide elongation.[11]
Ribosomal translocation
- aminoglycosides[7] (with all these three having other potential mechanisms of action as well), have evidence of inhibition of ribosomal translocation.
- Fusidic acid prevents the turnover of elongation factor G (EF-G) from the ribosome.
Termination
- peptidyl-tRNAfrom the ribosome.
- Puromycin has a structure similar to that of the tyrosinyl aminoacyl-tRNA. Thus, it binds to the ribosomal A site and participates in peptide bond formation, producing peptidyl-puromycin. However, it does not engage in translocation and quickly dissociates from the ribosome, causing a premature termination of polypeptide synthesis.
- Streptogramins also cause premature release of the peptide chain.[17]
Protein synthesis inhibitors of unspecified mechanism
Binding site
The following antibiotics bind to the 30S subunit of the ribosome:
The following antibiotics bind to the 50S ribosomal subunit:
- Chloramphenicol[17]
- Clindamycin[17]
- oxazolidinone)
- Macrolides[17]
- Telithromycin[17]
- Streptogramins[17]
- Retapamulin[18]
See also
References
- ^ Frank Lowy. "Protein Synthesis Inhibitors" (PDF). Columbia University. Retrieved 2021-01-27.
- ^ "7.344 Antibiotics, Toxins, and Protein Engineering, Spring 2007". MIT OpenCourseWare.
- PMID 9835522.
- PMID 18663023.
- S2CID 23170091.
- S2CID 5686856. Retrieved 2009-12-19.
- ^ a b Flavio Guzmán (2008-08-12). "Protein synthesis inhibitors: aminoglycosides mechanism of action animation. Classification of agents". Pharmamotion. Archived from the original on 2010-03-12.
- ^ a b Protein synthesis inhibitors: macrolides mechanism of action animation. Classification of agents Pharmamotion. Author: Gary Kaiser. The Community College of Baltimore County. Retrieved on July 31, 2009
- ^ a b c Page 212 in:
Title: Hugo and Russell's pharmaceutical microbiology
Authors: William Barry Hugo, Stephen P. Denyer, Norman A. Hodges, Sean P. Gorman
Edition: 7, illustrated
Publisher: Wiley-Blackwell, 2004
ISBN 0-632-06467-6Length: 481 pages
- ^ "Geneticin". Thermo Fisher Scientific.
- PMID 10318810.
- ^ Wisteria Lane cases → CLINDAMYCIN Archived 2012-07-18 at archive.today University of Michigan. Retrieved on July 31, 2009
- PMID 3167211.
- PMID 3391162.
- ^ S2CID 36166592.
- ^ PMID 12860123.
- ^ ISBN 978-0-07-149620-9.
- ^ a b Drugbank.ca > Showing drug card for Retapamulin (DB01256) Update Date: 2009-06-23